1. Home
  2. DK vs RCUS Comparison

DK vs RCUS Comparison

Compare DK & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

HOLD

Current Price

$43.45

Market Cap

2.5B

Sector

Energy

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.50

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DK
RCUS
Founded
2001
2015
Country
United States
United States
Employees
N/A
601
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
DK
RCUS
Price
$43.45
$23.50
Analyst Decision
Hold
Buy
Analyst Count
17
10
Target Price
$39.94
$31.90
AVG Volume (30 Days)
1.2M
891.7K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
2.19%
N/A
EPS Growth
95.67
N/A
EPS
N/A
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
$6.85
N/A
Revenue Next Year
N/A
$45.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.12
$7.92
52 Week High
$49.50
$28.72

Technical Indicators

Market Signals
Indicator
DK
RCUS
Relative Strength Index (RSI) 48.78 45.59
Support Level $43.00 $20.20
Resistance Level $44.62 $24.33
Average True Range (ATR) 2.27 1.15
MACD -0.37 -0.29
Stochastic Oscillator 24.59 21.52

Price Performance

Historical Comparison
DK
RCUS

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has three segments: Refining segment and Logistics segment and retail segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: